Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin

NCT03699332 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Carcinomatosis
Colorectal Cancer
Carcinoma
Neoplasms
Gastrointestinal Cancer

Interventions

DRUG: Indium-111-DOTA-Labetuzumab-IRDye800CW injection
RADIATION: SPECT/CT scan
PROCEDURE: CRS extended with dual-modality imaging

Sponsor

Radboud University Medical Center

Collaborators

[object Object]